Percutaneous Management of Mitral Regurgitation

Chapter

Abstract

Interventional cardiology has seen the advent of a new era in the transcatheter management of mitral valve disease. The challenges for all these devices will be to demonstrate safety and either equivalent or superior efficacy in comparison to traditional management strategies, whether medical or surgical. We must strive to properly select patients for these new therapies and to develop effective technologies to treat populations at high risk for surgery. Patience, collaboration, and vision are needed to fully develop these strategies.

Keywords

Migration Catheter Chromium Europe Cobalt 

References

  1. 1.
    Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.PubMedCrossRefGoogle Scholar
  2. 2.
    Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.PubMedGoogle Scholar
  3. 3.
    Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115(7):881–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–65.PubMedCrossRefGoogle Scholar
  5. 5.
    O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2–isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Carpentier A. Cardiac valve surgery–the “French correction”. J Thorac Cardiovasc Surg. 1983;86(3):323–37.PubMedGoogle Scholar
  7. 7.
    Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31(16):1958–66.PubMedCrossRefGoogle Scholar
  8. 8.
    Barlow JB, Pocock WA. The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J. 1963;12:76–7.PubMedGoogle Scholar
  9. 9.
    Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335(19):1417–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91(4):1022–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Seeburger J, Falk V, Borger MA, et al. Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: a egalite. Ann Thorac Surg. 2009;87(6):1715–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110(11 Suppl 1):II103–8.PubMedGoogle Scholar
  13. 13.
    Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45(3):381–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation. 2004;110(11 Suppl 1):II85–90.PubMedGoogle Scholar
  15. 15.
    Marwick TH. Restrictive annuloplasty for ischemic mitral regurgitation: too little or too much? J Am Coll Cardiol. 2008;51(17):1702–3.PubMedCrossRefGoogle Scholar
  16. 16.
    McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128(6):916–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Braun J, van de Veire NR, Klautz RJ, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85(2):430–6. discussion 436–437.PubMedCrossRefGoogle Scholar
  18. 18.
    Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Senechal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115(6):782–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg. 2001;71(4):1146–52. discussion 1152–1143.PubMedCrossRefGoogle Scholar
  20. 20.
    Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv. 2011;4(1):1–13.PubMedCrossRefGoogle Scholar
  21. 21.
    Rogers JH, Franzen O. Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation. Eur Heart J. 2011;32(19):2350–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674–81.PubMedCrossRefGoogle Scholar
  23. 23.
    Ussia GP, Barbanti M, Tamburino C. Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip system using conscious sedation. Catheter Cardiovasc Interv. 2010;75(7):1137–40.PubMedGoogle Scholar
  24. 24.
    Herrmann HC, Kar S, Siegel R, et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention. 2009;4(4):437–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol. 2011;57(16):1658–65.PubMedCrossRefGoogle Scholar
  26. 26.
    Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort. J Am Coll Cardiol. 2009;54(8):686–94.PubMedCrossRefGoogle Scholar
  27. 27.
    Feldman T, Foster E, Glower DG, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.PubMedCrossRefGoogle Scholar
  28. 28.
    Feldman T, Mauri L, Kar S, et al. EVEREST II randomized clinical trial: a critical assessment of the safety data in patients treated with the MitraClip. J Am Coll Cardiol. 2010;56(13, Supplement 1):B23.Google Scholar
  29. 29.
    Magne J, Girerd N, Senechal M, et al. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation. 2009;120(11 Suppl):S104–11.PubMedCrossRefGoogle Scholar
  30. 30.
    Argenziano M, Skipper E, Heimansohn D, et al. Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg. 2010;89(1):72–80. discussion p 80.PubMedCrossRefGoogle Scholar
  31. 31.
    Rogers JH, Yeo KK, Carroll JD, et al. Late surgical mitral valve repair after percutaneous repair with the MitraClip system. J Card Surg. 2009;24(6):677–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Glower D, Young JN, Alexander J, et al. EVEREST II randomized clinical trial: a critical assessment of anatomical predictors of de novo mitral valve replacement or following the MitraClip procedure. J Am Coll Cardiol. 2010;56(13, Supplement 1):B25.Google Scholar
  33. 33.
    Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31(11):1373–81.PubMedCrossRefGoogle Scholar
  34. 34.
    Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J. 2010;31(11):1382–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Johnston DR, Gillinov AM, Blackstone EH, et al. Surgical repair of posterior mitral valve prolapse: implications for guidelines and percutaneous repair. Ann Thorac Surg. 2010;89(5):1385–94.PubMedCrossRefGoogle Scholar
  36. 36.
    Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107(12):1609–13.PubMedCrossRefGoogle Scholar
  37. 37.
    Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734–43.PubMedCrossRefGoogle Scholar
  38. 38.
    DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly NE, Cohn LH. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg. 2010;139(1):76–83. discussion 83–74.PubMedCrossRefGoogle Scholar
  39. 39.
    Biner S, Perk G, Kar S, et al. Utility of combined two-dimensional and three-dimensional transesophageal imaging for catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr. 2011;24(6):611–17.PubMedCrossRefGoogle Scholar
  40. 40.
    Webb JG, Maisano F, Vahanian A, et al. Percutaneous suture edge-to-edge repair of the mitral valve. EuroIntervention. 2009;5(1):86–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114(5):377–80.PubMedCrossRefGoogle Scholar
  42. 42.
    Tops LF, Van de Veire NR, Schuijf JD, et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation. 2007;115(11):1426–32.PubMedCrossRefGoogle Scholar
  43. 43.
    Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009;120(4):326–33.PubMedCrossRefGoogle Scholar
  44. 44.
    Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation. 2006;113(6):851–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Harnek J, Webb JG, Kuck KH, et al. Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv. 2011;4(1):115–22.PubMedCrossRefGoogle Scholar
  46. 46.
    Sack S, Kahlert P, Bilodeau L, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Interv. 2009;2(4):277–84.PubMedCrossRefGoogle Scholar
  47. 47.
    Kim JH, Kocaturk O, Ozturk C, et al. Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: initial results in swine. J Am Coll Cardiol. 2009;54(7):638–51.PubMedCrossRefGoogle Scholar
  48. 48.
    Rogers JH, Macoviak JA, Rahdert DA, Takeda PA, Palacios IF, Low RI. Percutaneous septal sinus shortening. A novel procedure for the treatment of functional mitral regurgitation. Circulation. 2006;113(19):2329–34.PubMedCrossRefGoogle Scholar
  49. 49.
    Palacios IF, Condado JA, Brandi S, et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Catheter Cardiovasc Interv. 2007;69(4):513–18.PubMedCrossRefGoogle Scholar
  50. 50.
    Burr LH, Krayenbuhl C, Sutton MS. The mitral plication suture: a new technique of mitral valve repair. J Thorac Cardiovasc Surg. 1977;73(4):589–95.PubMedGoogle Scholar
  51. 51.
    Aybek T, Risteski P, Miskovic A, et al. Seven years’ experience with suture annuloplasty for mitral valve repair. J Thorac Cardiovasc Surg. 2006;131(1):99–106.PubMedCrossRefGoogle Scholar
  52. 52.
    Nagy ZL, Bodi A, Vaszily M, Szerafin T, Horvath A, Peterffy A. Five-year experience with a suture annuloplasty for mitral valve repair. Scand Cardiovasc J. 2000;34(5):528–32.PubMedCrossRefGoogle Scholar
  53. 53.
    Heuser RR, Witzel T, Dickens D, Takeda PA. Percutaneous treatment for mitral regurgitation: the QuantumCor system. J Interv Cardiol. 2008;21(2):178–82.PubMedCrossRefGoogle Scholar
  54. 54.
    Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg. 2006;81(1):42–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Miller DL, Morris JJ, Schaff HV, Mullany CJ, Nishimura RA, Orszulak TA. Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation. J Heart Valve Dis. 1995;4(2):160–5.PubMedGoogle Scholar
  56. 56.
    Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J. 1999;138(2 Pt 1):351–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Schoen FJ, Levy RJ. Pathology of substitute heart valves: new concepts and developments. J Card Surg. 1994;9(2 Suppl):222–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Jindani A, Neville EM, Venn G, Williams BT. Paraprosthetic leak: a complication of cardiac valve replacement. J Cardiovasc Surg (Torino). 1991;32(4):503–8.Google Scholar
  59. 59.
    Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv. 2006;68(4):528–33.PubMedCrossRefGoogle Scholar
  60. 60.
    Echevarria JR, Bernal JM, Rabasa JM, Morales D, Revilla Y, Revuelta JM. Reoperation for bioprosthetic valve dysfunction. A decade of clinical experience. Eur J Cardiothorac Surg. 1991;5(10):523–6. discussion 527.PubMedCrossRefGoogle Scholar
  61. 61.
    Sorajja P, Cabalka AK, Hagler DJ, et al. Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv. 2007;70(6):815–23.PubMedCrossRefGoogle Scholar
  62. 62.
    Kim MS, Casserly IP, Garcia JA, Klein AJ, Salcedo EE, Carroll JD. Percutaneous transcatheter closure of prosthetic mitral paravalvular leaks: are we there yet? JACC Cardiovasc Interv. 2009;2(2):81–90.PubMedCrossRefGoogle Scholar
  63. 63.
    Johri AM, Yared K, Durst R, et al. Three-dimensional echocardiography-guided repair of severe paravalvular regurgitation in a bioprosthetic and mechanical mitral valve. Eur J Echocardiogr. 2009;10(4):572–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Singh P, Manda J, Hsiung MC, et al. Live/real time three-dimensional transesophageal echocardiographic evaluation of mitral and aortic valve prosthetic paravalvular regurgitation. Echocardiography. 2009;26(8):980–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Mandegar MH, Roshanali F. Prosthetic valve malfunction after Amplatzer closure of paravalvular leak. Ann Thorac Surg. 2011;91(2):614.PubMedCrossRefGoogle Scholar
  66. 66.
    Rogers JH, Morris AS, Takeda PA, Low RI. Bioprosthetic leaflet erosion after percutaneous mitral paravalvular leak closure. JACC Cardiovasc Interv. 2010;3:122–3.PubMedCrossRefGoogle Scholar
  67. 67.
    Nietlispach F, Johnson M, Moss RR, et al. Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc Interv. 2010;3(7):759–65.PubMedCrossRefGoogle Scholar
  68. 68.
    Feldman T et al. Atlas of percutaneous edge-to-edge mitral valve repair. New York: Springer; 2013.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineUC Davis Medical CenterSacramentoUSA
  2. 2.Interventional Cardiology, Cardiac Catheterization LaboratoryWashington University School of Medicine, One Barnes-Jewish HospitalSt. LouisUSA

Personalised recommendations